(Q44128229)
Statements
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS) (English)
Jean-Claude Ansquer
Christelle Foucher
Stephanie Rattier
George Steiner
DAIS Investigators